08:00 , Jan 7, 2002 |  BioCentury  |  Finance

Foresight in hindsight

Foresight in hindsight To mark the 10th Anniversary of the Buyside View, we have picked selected quotes from previous years - some prescient, others providing interesting historical perspective - and printed them below along with...
08:00 , Mar 20, 2000 |  BC Extra  |  Financial News

Spotfire raises $15 million

Spotfire ( Cambridge , Mass.), a provider of internet-based decision analytics software and services, raised $15 million in a mezzanine round of venture financing. Investors included The Sprout Group; Pequot Capital Management; Soros Fund Management;...
08:00 , Jan 10, 2000 |  BioCentury  |  Finance

Drilling down deeper

For the past two years, investors have made great returns in the top tier biotechs, driving them up 79 percent in 1998 and 53 percent in 1999. Now the rotation into companies with real products,...
07:00 , Oct 4, 1999 |  BioCentury  |  Finance

3Q Market Review: Biobulls make their case

Overlooking the shaky conditions of the overall stock markets in the past two weeks, the reality is that the biotech sector has been on a tear. The BioCentury 100 was up 11 out of the...
08:00 , Jan 18, 1999 |  BioCentury  |  Finance

Crowded but muted

The Hambrecht & Quist Healthcare Conference, as the first financial meeting every year, is always a place where companies test the mood of the investment community. The buyside's mood has particular urgency this year for...
07:00 , Sep 8, 1997 |  BioCentury  |  Emerging Company Profile

CuraGen Corp.

CuraGen Corp. New Haven, Conn. Technology: Genomics/bioinformatics platform Disease focus: N/A Clinical status: N/A Founded: 1993 by Jonathan Rothberg and Gregory Went Corporate partners: Pioneer Hi-Bred International Inc., Genentech Inc. , Biogen Inc. , Glaxo...